A comprehensive review published in Cellular & Molecular Biology Letters synthesizes current evidence on Musashi-2 (MSI2), characterizing the RNA-binding protein as a central regulator of RNA fate that connects post-transcriptional control to cell-state transitions across diverse biological systems. Although RNA-binding proteins are recognized as major determinants of gene regulation in physiology and disease, the mechanisms linking individual post-transcriptional regulators to disease states and therapeutic vulnerabilities have remained incompletely understood. Evolutionarily conserved as a member of the Musashi family, MSI2 was initially characterized within stem and progenitor cell compartments, but ongoing research now implicates the protein across a broad spectrum of hematological malignancies, solid tumors, and selected non-neoplastic disorders.
From molecular architecture to disease relevance, the review details how MSI2 recurrently acts as a post-transcriptional hub that stabilizes pathogenic cellular states by regulating messenger RNA stability, translation, alternative splicing, and, in selected contexts, non-coding RNA processing. Through these multifaceted regulatory activities, MSI2 directly influences key pathological properties, including stemness, differentiation blockade, proliferative fitness, stress adaptation, epithelial–mesenchymal transition, metastasis, and therapy resistance. Rather than operating as a universal oncogenic switch, the biological output of MSI2 is context-dependent and dynamically shaped by tissue lineage identity, target transcript repertoires, interacting cofactors, upstream regulatory circuits, and cellular environmental stress.
In evaluating the translational landscape, the authors identify MSI2 as an emerging biomarker for aggressive and treatment-adapted disease states, alongside ongoing efforts to target the protein via direct or indirect therapeutic strategies. However, the review emphasizes that translating MSI2 into a viable therapeutic node faces significant hurdles, including structural tractability, context-specific dependencies, potential toxicities in normal stem cell compartments, and compensatory mechanisms within wider RNA regulatory networks. Overall, current evidence establishes MSI2 as a context-responsive post-transcriptional organizer and an important conceptual entry point for understanding how pathological states are established, maintained, and potentially destabilized through targeted intervention.
Subject of Research: Musashi-2 regulation of RNA fate in disease pathogenesis and targeted therapeutics
Article Title: Musashi-2 (MSI2): a central node connecting RNA regulation, disease pathogenesis, and targeted therapeutics
Article References: Mo, T., Zhang, L., Jiang, W., Wang, W., Wang, K., & Chen, C. (2026). Musashi-2 (MSI2): a central node connecting RNA regulation, disease pathogenesis, and targeted therapeutics. Cellular & Molecular Biology Letters. https://doi.org/10.1186/s11658-026-01046-z
Image Credits: AI Generated
DOI: 10.1186/s11658-026-01046-z
Keywords: Musashi-2, RNA-binding proteins, post-transcriptional regulation, hematological malignancies, solid tumors, targeted therapeutics, biomarkers, stem cells, MSI2, central, node, connecting
News Source: Drew Townsend. (November 6, 2026). Review Synthesizes Musashi-2 Mechanisms in Post-Transcriptional Disease Regulation. Scienmag.
